HLA Demographics Study in Adults With Type 1 Diabetes

Part of paid clinical trials in San Francisco, California.

Sponsor
GentiBio, Inc
Study ID
NCT06860516
Status
Recruiting

Conditions

  • Diabetes Mellitus, Type I

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Not accepted

Interventions

  • blood draw or cheek swab — OTHER
    a blood draw or cheek swab for testing of HLA-DRB1\*04:01

Study Details

This is a study to evaluate the HLA-DRB1\*04:01 genotype in adults that have been diagnosed with type 1 diabetes

Key Dates

Start date
Jun 6, 2025
Status verified
Apr 2026
Primary completion
Jan 30, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: all participants
    aged ≥ 18 to ≤ 55 years recently (within 6 months of the study visit) diagnosed with T1D

Primary Outcome Measure

HLA DRB1*04:01 positive [ Time Frame: Day 1 ]

Central Contacts

Locations (5)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94158
Rebecca Wesch, Recruitment Coordinator
844-813-8273
Stephen Gitelman, MD (PRINCIPAL_INVESTIGATOR)
University of Florida- GainesvilleGainesvilleFlorida32610
Jennifer Hosford
352-294-5759
Michael Haller, MD (PRINCIPAL_INVESTIGATOR)
Joslin Diabetes CenterBostonMassachusetts02215
Michelle Zhang
888-813-8669
Jason Gaglia, MD (PRINCIPAL_INVESTIGATOR)
Icahn School of Medicine at Mount SinaiNew YorkNew York10029
Carol Levy, MD
212-241-0068
Carol Levy, MD (PRINCIPAL_INVESTIGATOR)
University of North Carolina at Chapel HillChapel HillNorth Carolina27514
Alex Kass
984-974-3004
Klara Klein, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in San Francisco, CA

Related Studies